✦ LIBER ✦

Optimal retention levels, given the joint survival of cedent and reinsurer

✍ Scribed by Kaishev, V. K.

Book ID: 121692811
Publisher: Taylor and Francis Group
Year: 2004
Tongue: English
Weight: 489 KB
Volume: 2004
Category: Article
ISSN: 0346-1238
DOI: 10.1080/03461230410020437

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Optimal Reciprocal Reinsurance Treaties

Optimal Reciprocal Reinsurance Treaties Under the Joint Survival Probability and the Joint Profitable Probability

✍ Jun Cai; Ying Fang; Zhi Li; Gordon E. Willmot 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 649 KB

Optimal combination of quota-share and s

Optimal combination of quota-share and stop-loss reinsurance treaties under the joint survival probability

✍ Fang, Y.; Qu, Z. 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 204 KB

Optimal process levels for the joint con

Optimal process levels for the joint control of variables and attributes

✍ F.J. Arcelus; M.A. Rahim 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 469 KB

A Four-Level Hierarchical Approach to th

A Four-Level Hierarchical Approach to the Joint Problem of System Identification and Optimization and Its Application to a Batch Fermenter Using Microprocessors

📂 Article 📅 1981 🏛 Institute of Electrical and Electronics Engineers ⚖ 878 KB

Calculated prostate carcinoma volume : T

Calculated prostate carcinoma volume : The optimal predictor of 3-year prostate specific antigen (PSA) failure free survival after surgery or radiation therapy of patients with pretreatment PSA levels of 4-20 nanograms per milliliter

✍ Anthony V. D'Amico; Richard Whittington; Irving Kaplan; Clair Beard; Delray Schu 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB 👁 2 views

## Background: In this study, the authors evaluated whether a clinically relevant stratification of prostate specific antigen (psa) failure free survival (bned) after definitive local therapy could be made for patients with prostate carcinoma clinically classified as t1 or t2 and pretreatment psa l